BOC-D-serine methyl ester, systematically named (R)-methyl 2-((tert-butoxycarbonyl)amino)-3-hydroxypropanoate, has the empirical formula C₉H₁₇NO₅, a molar mass of 219.24 g/mol, and a CAS registry number of 95715-86-9. The product is not assigned a hardware model number; its identity is specified by the CAS registry entry, bonding topology, and stereochemical descriptor. The material is typically a white to off-white crystalline powder with a free primary hydroxyl, a Boc-protected α-amino group, and a methyl ester-protected carboxyl group. This reactivity hierarchy determines its use as a protected D-serine intermediate in solution-phase peptide synthesis. The tert-butoxycarbonyl group is removed by anhydrous acid, while the methyl ester is removed by mild basic hydrolysis or transesterification. The D-configuration distinguishes it from the L-serine derivative, and the methyl ester distinguishes it from Boc-D-serine free acid. The methyl ester increases solubility in dichloromethane, tetrahydrofuran, ethyl acetate, and dimethylformamide relative to the unprotected polar carboxylate, while reducing aqueous solubility. This solubility shift is relevant in batch extraction and anhydrous coupling operations. The compound is not intended for direct pharmaceutical use; it is manufactured as a research and industrial intermediate.

Release certificates for commercial lots commonly list chromatographic purity, water content, residual solvent profile, optical rotation, and appearance. HPLC purity is usually assessed on a reverse-phase C18 column with UV detection at 210 nm and an acceptance threshold of at least 98.0% area. Water content is determined by Karl Fischer coulometric or volumetric titration in accordance with USP <921>. Residual solvents are reported from headspace gas chromatography referenced to USP <467>. Optical rotation is measured at 589 nm and 20°C by polarimetry referenced to USP <781>; the sign is positive for the D-enantiomer, but numerical limits vary across suppliers. Storage of closed containers is recommended at 2–8°C under nitrogen or argon. The product is hygroscopic; if exposed to relative humidity above 60%, vacuum drying at 30°C for 4–6 h is recommended before use. Avoid contact with strong bases, primary or secondary amines, hydrazine, and acid chlorides.

What limits methyl ester saponification without α-carbon epimerization?

The critical process limit in using BOC-D-serine methyl ester is not Boc removal but the methyl ester saponification. When hydrolysis is performed with lithium hydroxide, the D-configured α-carbon is vulnerable to base-mediated epimerization. The ester carbonyl increases α-proton acidity, and the enolate formed at elevated pH can reprotonate from either face, producing a D/L mixture. Temperature control is therefore more critical than base concentration above pH 11. The reaction is maintained at 0–5°C using 0.5–1.0 M lithium hydroxide in tetrahydrofuran/water 3:1. In a 50 L glass-lined stirred tank, rapid addition of lithium hydroxide has been observed to raise the process temperature by 4–6°C when dosing is completed in under 15 minutes. Extending the addition to 45–60 minutes with jacket control at -10°C holds the reactant within the 0–5°C window.

Reaction age is typically 60–90 minutes, after which the batch is quenched into 10% aqueous citric acid to pH 3–4. The resulting Boc-D-serine is extracted into ethyl acetate, washed with brine, dried over anhydrous sodium sulfate, and concentrated under vacuum at 30°C. Residual moisture is controlled to ≤0.2% before subsequent coupling. In-process TLC on silica gel 60 F₂₅₄ using dichloromethane/methanol 9:1 is used to verify disappearance of the methyl ester; the product is visualized by ninhydrin or charring after Boc removal. Enantiomeric purity may be confirmed by chiral HPLC or by Marfey’s analysis with LC-MS. Alternative methyl ester cleavage by esterase enzymes avoids epimerization, but published data for this specific configuration is limited, and lower throughput usually restricts enzyme-mediated saponification to small-scale preparative work.

When the methyl ester is retained as C-terminal protection, the Boc group is removed instead. Deprotection is conducted with 30–50% trifluoroacetic acid in dichloromethane at 0–20°C for 30–60 minutes in the presence of 2–5% triisopropylsilane as carbocation scavenger. The methyl ester remains essentially unaffected because the reaction is anhydrous and strongly acidic. The free hydroxyl does not require protection under these conditions, but extended treatment above 24 h can lead to tert-butyl side-chain alkylation at trace levels. The crude trifluoroacetate salt is isolated by trituration with cold diethyl ether or methyl tert-butyl ether to remove residual trifluoroacetic acid and silane residues.

Coupling performance and side-chain hydroxyl interference in DCC/HOBt and HATU protocols

When BOC-D-serine methyl ester is first saponified to Boc-D-serine, coupling to amino esters or resin-bound amines is performed under low-temperature activation. DCC/HOBt activation in dimethylformamide or dichloromethane at 0–5°C requires a pre-activation time of 10–15 minutes. The unprotected β-hydroxyl can become O-acylated if the active ester is aged longer than 30 minutes at 20°C. HATU/DIPEA provides faster activation, but the free hydroxyl may consume the uronium reagent; 1.0–1.05 equivalents of HATU relative to the acid are used, and the amine component is added within 2–3 minutes after activation. The resulting coupling efficiency depends on amine steric hindrance, and published data for this exact derivative under peptide synthesizer automation is limited.

If the methyl ester is retained as C-terminal protection, the Boc group is removed first, and the resulting D-serine methyl ester trifluoroacetate salt is neutralized with N-methylmorpholine or DIPEA. The free amino group is then coupled to an N-protected amino acid or peptide acid using standard carbodiimide or phosphonium/uronium reagents. This route avoids the base-catalyzed saponification step entirely and therefore minimizes α-carbon epimerization. Because the side-chain hydroxyl remains unprotected, O-silylation with tert-butyldimethylsilyl chloride or O-benzylation may be introduced before coupling when downstream chemistry requires orthogonality. This increases step count but reduces side-chain competition in complex sequences.

When Fmoc-D-serine methyl ester and Boc-L-serine methyl ester are considered as replacements

Fmoc-D-serine methyl ester carries a base-labile Fmoc group rather than an acid-labile Boc group. This change is operationally significant. BOC-D-serine methyl ester is stable to the aqueous basic conditions used for saponification; therefore, selective methyl ester hydrolysis can be completed before N-deprotection. The Fmoc derivative, by contrast, may undergo premature N-Fmoc cleavage during the same methyl ester hydrolysis. For this reason, the Boc derivative is preferred when the C-terminal methyl ester must be removed before N-deprotection. In Fmoc/tBu solid-phase peptide synthesis, methyl ester protection is generally not used as the resin-bound C-terminal anchor; 2-chlorotrityl chloride resin or preloaded Wang-type linkers are more common. The Boc derivative fits solution-phase routes and some Boc/benzyl strategies.

Boc-L-serine methyl ester is the enantiomeric counterpart with the same molecular formula and molar mass. Its process behavior is similar, but the stereochemical output is opposite. In peptide sequences requiring D-amino acid substitution, inadvertent use of the L-form introduces an epimer that can alter secondary structure, receptor recognition, or proteolytic stability. Chiral HPLC or optical rotation should be used to confirm enantiomeric identity before charging the material to a GMP or high-value synthesis. D-serine methyl ester hydrochloride has a free amino group and can couple directly to an activated carboxyl without Boc removal; however, the lack of N-protection reduces chemoselectivity in multistep routes. Boc-D-serine benzyl ester offers C-terminal benzyl protection removed by hydrogenolysis over palladium on carbon, providing an alternative when the methyl ester is too labile under basic aqueous conditions.

Handling incompatibilities for BOC-D-serine methyl ester include strong aqueous alkali above pH 12, primary and secondary amines, hydrazine, and excessive moisture. For process development, in-process chiral HPLC or polarimetry should be used to confirm enantiomeric purity before the product is converted to a peptide, because D/L epimerization at 0.5% to 2% can be difficult to remove in later chromatographic steps.